ECM Weekly (1 Jun 2019) - Hansoh, China East Edu, GSX, CSSC (HK) Shipping, China Tobacco
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for upcoming IPOs.
There were no new IPO filings in Asia but there will still be a handful of listing trickling in as we approach the end of Q2.
Starting in Hong Kong, Hansoh Pharmaceutical (3692 HK), launched its bookbuild on Thursday with a strong line up of cornerstone investors. The company had also announced a positive development just before it launched its IPO. Ke Yan, CFA, FRM discussed the company's valuation and the license-in from Viela Bio in:
- Hansoh Pharma (翰森制药) IPO: Strong Cornerstone Line-Up, Upside at Low End
- Hansoh Pharma (翰森制药) IPO: Inebilizumab License-In from Viela Bio a Symbolic Deal
Other IPOs that have opened their books this week include China East Education (667 HK), Tai Hing (1719303D HK), China Tobacco International (HK) (6055 HK), and CSSC (Hong Kong) Shipping Co Ltd (3877 HK).
Beyond that, ESR Cayman (ESR HK) will be opening its book next week. For early thoughts on valuation, Sumeet Singh has covered the company extensively in:
- ESR Cayman Pre-IPO - Updates from PHIP - Growth Remains on Track
- ESR Cayman Pre-IPO - Updated Valuation and Key Risks
In the U.S, GSX Techedu (GSX US) will debut next week and we have covered the IPO in:
Other markets have been fairly quiet. In Australia, there are news on Home Consortium and Education Center of Australia planning for their IPO while India will likely see more activity after elections being out of the way.
Accuracy Rate:
Our overall accuracy rate is 72.4% for IPOs and 63.9% for Placements
(Performance measurement criteria is explained at the end of the note)
No new IPO filings this week
Below is a snippet of our IPO tool showing upcoming events for the next week. The IPO tool is designed to provide readers with timely information on all IPO related events (Book open/closing, listing, initiation, lock-up expiry, etc) for all the deals that we have worked on. You can access the tool here or through the tools menu.
News on Upcoming IPOs
- Alibaba listing offers Hong Kong a shot at the one that got away
- HDB Financial plans US$1bn–$1.5bn IPO over next 12 months
- Education Centre of Australia hits go on IPO set to value it at $500m
Analysis on Upcoming IPOs
- Hansoh Pharma (翰森制药) IPO: Strong Cornerstone Line-Up, Upside at Low End
- Hansoh Pharma (翰森制药) IPO: Inebilizumab License-In from Viela Bio a Symbolic Deal
- China East Education (中国东方教育) IPO - Bold Expansion Plans
- CSSC (HK) Shipping IPO: Under-Depreciation & Rich Valuation
- GSX Techedu (跟谁学) IPO Review - Profitable Online Education Company
- Tai Hing (太興) IPO Review - Palatable from the Low-End
- China Tobacco Intl (HK) IPO: Geopolitical Risk and Valuation
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
- ECM Weekly (22 Jun 2019) - Alibaba, Budweiser Brewing Co, Ascentage, CIMC Vehicle, Impro Precision22 Jun 2019
- ECM Weekly (15 Jun 2019) - Budweiser Brewing Co, Jinxin Fertility, Wanda Sports, Hansoh Pharma15 Jun 2019
- ECM Weekly (8 Jun 2019) -ESR Cayman, Shanghai Henlius, Edvantage, JH Education08 Jun 2019
- ECM Weekly (1 Jun 2019) - Hansoh, China East Edu, GSX, CSSC (HK) Shipping, China Tobacco01 Jun 2019
- Hansoh Pharma (翰森制药) IPO: Strong Cornerstone Line-Up, Upside at Low End30 May 2019
- Hansoh Pharma (翰森制药) IPO: Inebilizumab License-In from Viela Bio a Symbolic Deal29 May 2019
- ECM Weekly (25 May 2019) - ESR Cayman, Hansoh Pharma, Tai Hing, China East Edu, Haitong UniTrust25 May 2019